These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32106836)

  • 21. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
    Lu CL; Ji Y; Ge D; Guo J; Ding JY
    Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
    Kitano H; Chung JY; Noh KH; Lee YH; Kim TW; Lee SH; Eo SH; Cho HJ; Choi CH; Inoue S; Hanaoka J; Fukuoka J; Hewitt SM
    J Transl Med; 2017 Jun; 15(1):138. PubMed ID: 28623914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.
    Tsoyi K; Osorio JC; Chu SG; Fernandez IE; De Frias SP; Sholl L; Cui Y; Tellez CS; Siegfried JM; Belinsky SA; Perrella MA; El-Chemaly S; Rosas IO
    Am J Respir Cell Mol Biol; 2019 Jun; 60(6):659-666. PubMed ID: 30562054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The expression of heparanase and vascular endothelial growth factor-C in human lung cancer].
    Tian H; Liu XX; Wang SZ
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(16):976-9. PubMed ID: 15363233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
    Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
    Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor level as a prognostic determinant of small cell lung cancer in Japanese patients.
    Hasegawa Y; Takanashi S; Okudera K; Kumagai M; Hayashi A; Morimoto T; Okumura K
    Intern Med; 2005 Jan; 44(1):26-34. PubMed ID: 15704659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
    Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum angiopoietin-2 as a clinical marker for lung cancer.
    Park JH; Park KJ; Kim YS; Sheen SS; Lee KS; Lee HN; Oh YJ; Hwang SC
    Chest; 2007 Jul; 132(1):200-6. PubMed ID: 17505039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
    Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
    Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
    Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.
    Li J; Hu YM; Du YJ; Zhu LR; Qian H; Wu Y; Shi WL
    BMC Cancer; 2014 Nov; 14():848. PubMed ID: 25410981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.
    Kozłowski M; Laudański W; Mroczko B; Szmitkowski M; Milewski R; Łapuć G
    Adv Med Sci; 2013; 58(2):227-34. PubMed ID: 23773968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
    Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
    Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
    Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
    Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
    Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.